Max Healthcare Institute · NSE: MAXHEALTH · BSE: 543220
Q3 FY23 results · Oct–Dec 2022
Max Healthcare Institute reported revenue from operations of ₹1,141.24 crore (up 17.2% from Q3 FY22) and net profit of ₹222.41 crore (up 17.2% from Q3 FY22) for Q3 FY23 (Oct–Dec 2022), on a consolidated basis.
| Item | Q3 FY23 | Q3 FY22 | YoY | Q2 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,141.24 | 974.16 | +17.2% | 1,137.12 | +0.4% |
| Other income | 45.15 | 48.61 | −7.1% | 25.82 | +74.9% |
| Total income | 1,186.39 | 1,022.77 | +16.0% | 1,162.94 | +2.0% |
| Profit before tax | 281.44 | 213.04 | +32.1% | 265.22 | +6.1% |
| Net profit for the period | 222.41 | 189.75 | +17.2% | 457.35 | −51.4% |
| EPS, basic (₹) | 2.29 | 1.96 | +16.9% | 4.72 | −51.5% |
| Net margin (%) | 19.5 | 19.5 | 40.2 |
| Item | Q3 FY23 | Q3 FY22 | YoY | Q2 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 481.97 | 397.72 | +21.2% | 474.14 | +1.7% |
| Other income | 44.04 | 42.15 | +4.5% | 32.16 | +36.9% |
| Total income | 526.01 | 439.87 | +19.6% | 506.30 | +3.9% |
| Profit before tax | 157.05 | 109.65 | +43.2% | 144.01 | +9.1% |
| Net profit for the period | 122.14 | 103.81 | +17.7% | 358.64 | −65.9% |
| EPS, basic (₹) | 1.26 | 1.07 | +17.8% | 3.70 | −65.9% |
| Net margin (%) | 25.3 | 26.1 | 75.6 |
Consolidated
- Filed with BSE
- 02 Feb 2023, 17:14 IST
- Board meeting
- 02 Feb 2023
- Period
- 01 Oct 2022 to 31 Dec 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 02 Feb 2023, 17:14 IST
- Board meeting
- 02 Feb 2023
- Period
- 01 Oct 2022 to 31 Dec 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE